MPH Health Care AG banner

MPH Health Care AG
XETRA:93M1

Watchlist Manager
MPH Health Care AG Logo
MPH Health Care AG
XETRA:93M1
Watchlist
Price: 20.4 EUR Market Closed
Market Cap: €87.3m

MPH Health Care AG
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

MPH Health Care AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
MPH Health Care AG
XETRA:93M1
Cash from Operating Activities
€781.5k
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Cash from Operating Activities
-$102.7m
CAGR 3-Years
1%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash from Operating Activities
€5.9B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Merck KGaA
XETRA:MRK
Cash from Operating Activities
€3.9B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
6%
Dermapharm Holding SE
XETRA:DMP
Cash from Operating Activities
€229.2m
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
N/A
A
Apontis Pharma AG
XETRA:APPH
Cash from Operating Activities
-€2.9m
CAGR 3-Years
N/A
CAGR 5-Years
-65%
CAGR 10-Years
N/A
No Stocks Found

MPH Health Care AG
Glance View

Market Cap
87.3m EUR
Industry
Pharmaceuticals

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

93M1 Intrinsic Value
9.61 EUR
Overvaluation 53%
Intrinsic Value
Price €20.4

See Also

What is MPH Health Care AG's Cash from Operating Activities?
Cash from Operating Activities
781.5k EUR

Based on the financial report for Dec 31, 2024, MPH Health Care AG's Cash from Operating Activities amounts to 781.5k EUR.

What is MPH Health Care AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-24%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett